Medical Pharmaceutical Supply – Sodium Chloride Injection

The contract entails the supply of sterile Sodium Chloride Injection (0.9%), USP, in 500 mL volumes, fully compliant with the Department of Defense’s Medical Supply Chain Pharmaceutical Federal Supply Activity’s packaging, labeling, and shelf-life specifications. All deliveries must adhere strictly to DLA’s medical standards to ensure product integrity and readiness for military medical use, with performance obligations centered at Fort Stewart, Georgia, under the assigned ZIP code 31314-5185. The solicitation, categorized as a subcontract under NAICS code 325412, was posted on July 16, 2026, with a firm response deadline of July 22, 2026, indicating a narrow window for bidder submissions. Although no specific set-aside designation is outlined, the procurement is managed by the Department of Defense through its medical supply chain infrastructure, emphasizing standardized, high-reliability pharmaceutical logistics for federal healthcare operations. Detailed requirements and submission protocols are accessible via the designated DIBBS portal.